Fort Myers firm gains ground

FORT MYERS — In an earnings report released Thursday, NeoGenomics Inc. reports it grew revenues 47% to $12.9 million in the fourth quarter compared with the same quarter a year ago, and posted a net income of $152,000 in Q4 compared with a net loss of $377,000 during the same time in 2010.

The results produced an earnings of $0 per share, in line with analysts' expectations.

The company, which provides cancer-focused genetic testing services, says in a release that it increased its test volume 57% in the latest quarter. Although its average revenue per test decreased 6%, it improved its average cost of goods sold per test by 7%, which offset the lower revenue per test.